Keywords: millennium, net, income, beats, forecasts, usa, pharmaceuticals
Millennium's 2007 net income beats forecasts
Article | 18 February 2008
The USA's Millennium Pharmaceuticals' 2007 non-generally-accepted accounting principles net income beat expectations, reaching $86.9 million, up from $38.6 million in the previous year, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
